These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26919738)

  • 1. Longitudinal evaluation of regulatory T-cell dynamics on HIV-infected individuals during the first 2 years of therapy.
    Nobrega C; Horta A; Coutinho-Teixeira V; Martins-Ribeiro A; Baldaia A; Rb-Silva R; Santos CL; Sarmento-Castro R; Correia-Neves M
    AIDS; 2016 May; 30(8):1175-86. PubMed ID: 26919738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic function in HIV-infection.
    Kolte L
    Dan Med J; 2013 Apr; 60(4):B4622. PubMed ID: 23651726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
    DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
    Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-Cell Activation Independently Associates With Immune Senescence in HIV-Infected Recipients of Long-term Antiretroviral Treatment.
    Cobos Jiménez V; Wit FW; Joerink M; Maurer I; Harskamp AM; Schouten J; Prins M; van Leeuwen EM; Booiman T; Deeks SG; Reiss P; Kootstra NA;
    J Infect Dis; 2016 Jul; 214(2):216-25. PubMed ID: 27073222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal changes of peripheral blood DC subsets and regulatory T cells in Chinese chronic HIV-1-infected patients during antiretroviral therapy.
    Zhang M; Zhang H; Zhang T; Ji Y; Jiao Y; Wu H
    PLoS One; 2012; 7(5):e37966. PubMed ID: 22701538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: the IMMUNEF clinical trial.
    Soria A; Trabattoni D; Squillace N; Rainone V; Gnudi F; Clerici M; Gori A; Bandera A
    PLoS One; 2015; 10(2):e0117118. PubMed ID: 25671649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and Significance of CD4+CD25+CD127dim Regulatory T Cells in Individuals with Severe Aplastic Anemia.
    Qi W; Ren Y; Fu R; Wang H; Liu C; Shao Z
    Turk J Haematol; 2015 Sep; 32(3):220-7. PubMed ID: 25912955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
    Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
    AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression.
    Zhang JC; Zhang HJ; Li Y; Jing D; Liu Q; Zhao K; Liu QQ; Zhuang Y; Kang WZ; Sun YT
    Scand J Infect Dis; 2013 May; 45(5):368-77. PubMed ID: 23186319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.
    Goicoechea M; Smith DM; Liu L; May S; Tenorio AR; Ignacio CC; Landay A; Haubrich R
    J Infect Dis; 2006 Jul; 194(1):29-37. PubMed ID: 16741879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naive and Memory CD4⁺ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART.
    Tanaskovic S; Fernandez S; Saraswati H; Yunihastuti E; Gani RA; Djauzi S; Price P
    Viral Immunol; 2016 Apr; 29(3):176-83. PubMed ID: 27035638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory T Cell Counts and Development of Malignancy in Patients with HIV Infection.
    Politou M; Boti S; Androutsakos T; Kontos A; Pouliakis A; Kapsimali V; Panayiotakopoulos G; Kordossis T; Karakitsos P; Sipsas NV
    Curr HIV Res; 2020; 18(3):201-209. PubMed ID: 32234003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological determinants of immune reconstitution in HIV-infected patients receiving antiretroviral therapy: the role of interleukin 7 and interleukin 7 receptor α and microbial translocation.
    Rajasuriar R; Booth D; Solomon A; Chua K; Spelman T; Gouillou M; Schlub TE; Davenport M; Crowe S; Elliott J; Hoy J; Fairley C; Stewart G; Cameron P; Lewin SR
    J Infect Dis; 2010 Oct; 202(8):1254-64. PubMed ID: 20812848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype alterations in regulatory T-cell subsets in primary HIV infection and identification of Tr1-like cells as the main interleukin 10-producing CD4+ T cells.
    Chevalier MF; Didier C; Petitjean G; Karmochkine M; Girard PM; Barré-Sinoussi F; Scott-Algara D; Weiss L
    J Infect Dis; 2015 Mar; 211(5):769-79. PubMed ID: 25281758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe immune dysregulation affects CD4⁺CD25(hi)FoxP3⁺ regulatory T cells in HIV-infected patients with low-level CD4 T-cell repopulation despite suppressive highly active antiretroviral therapy.
    Méndez-Lagares G; Pozo-Balado MM; Genebat M; García Pergañeda A; Leal M; Pacheco YM
    J Infect Dis; 2012 May; 205(10):1501-9. PubMed ID: 22457273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    Gupta RK; Brown AE; Zenner D; Rice B; Yin Z; Thomas HL; Pozniak A; Abubakar I; Delpech V; Lipman M
    AIDS; 2015 Jul; 29(11):1363-8. PubMed ID: 26091298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.
    Harrer T; Plettenberg A; Arastéh K; Van Lunzen J; Fätkenheuer G; Jaeger H; Janssens M; Burny W; Collard A; Roman F; Loeliger A; Koutsoukos M; Bourguignon P; Lavreys L; Voss G
    Vaccine; 2014 May; 32(22):2657-65. PubMed ID: 24144472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dual impact of HIV-1 infection and aging on naïve CD4 T-cells: additive and distinct patterns of impairment.
    Rickabaugh TM; Kilpatrick RD; Hultin LE; Hultin PM; Hausner MA; Sugar CA; Althoff KN; Margolick JB; Rinaldo CR; Detels R; Phair J; Effros RB; Jamieson BD
    PLoS One; 2011 Jan; 6(1):e16459. PubMed ID: 21298072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
    Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
    Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory T cells in HIV-infected immunological nonresponders are increased in blood but depleted in lymphoid tissue and predict immunological reconstitution.
    Gaardbo JC; Hartling HJ; Ronit A; Springborg K; Gjerdrum LM; Ralfkiær E; Thorsteinsson K; Ullum H; Andersen ÅB; Nielsen SD
    J Acquir Immune Defic Syndr; 2014 Aug; 66(4):349-57. PubMed ID: 24784764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.